Medherant awarded manufacturing grant from Innovate UK
Medherant has been awarded a grant by Innovate UK to help it upscale production of its TEPI Patch drug delivery system for clinical trials.
TEPI Patch technology enables the development of drug-in-adhesive patch products “with better adhesion and more efficient delivery of drugs through the skin over a prolonged period,” according to the firm.
Medherant's first product, an Ibuprofen TEPI Patch, is currently being assessed in Phase I clinical development with initial results expected in later this year.
Read more: http://www.pharmatimes.com/news/medherant_awarded_manufacturing_grant_from_innovate_uk_1254351
TEPI Patch technology enables the development of drug-in-adhesive patch products “with better adhesion and more efficient delivery of drugs through the skin over a prolonged period,” according to the firm.
Medherant's first product, an Ibuprofen TEPI Patch, is currently being assessed in Phase I clinical development with initial results expected in later this year.
Read more: http://www.pharmatimes.com/news/medherant_awarded_manufacturing_grant_from_innovate_uk_1254351